nodes	percent_of_prediction	percent_of_DWPC	metapath
Ribavirin—ENPP1—Vitamin B2 (riboflavin) metabolism—SLC52A3—esophageal cancer	0.103	0.338	CbGpPWpGaD
Ribavirin—NT5C2—neck—esophageal cancer	0.0169	0.0816	CbGeAlD
Ribavirin—NT5C2—Abacavir transport and metabolism—ABCB1—esophageal cancer	0.0165	0.0542	CbGpPWpGaD
Ribavirin—SLC28A3—trachea—esophageal cancer	0.0122	0.059	CbGeAlD
Ribavirin—NT5C2—bronchus—esophageal cancer	0.0113	0.0546	CbGeAlD
Ribavirin—NT5C2—smooth muscle tissue—esophageal cancer	0.0111	0.0535	CbGeAlD
Ribavirin—SLC28A3—digestive system—esophageal cancer	0.0105	0.0507	CbGeAlD
Ribavirin—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—SLC52A3—esophageal cancer	0.0105	0.0344	CbGpPWpGaD
Ribavirin—NT5C2—trachea—esophageal cancer	0.0102	0.0491	CbGeAlD
Ribavirin—ENPP1—lung—esophageal cancer	0.01	0.0483	CbGeAlD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—XRCC3—esophageal cancer	0.00929	0.0305	CbGpPWpGaD
Ribavirin—IMPDH1—bronchus—esophageal cancer	0.00919	0.0444	CbGeAlD
Ribavirin—IMPDH1—smooth muscle tissue—esophageal cancer	0.00899	0.0434	CbGeAlD
Ribavirin—SLC28A3—lung—esophageal cancer	0.00878	0.0424	CbGeAlD
Ribavirin—NT5C2—digestive system—esophageal cancer	0.00874	0.0422	CbGeAlD
Ribavirin—IMPDH1—trachea—esophageal cancer	0.00825	0.0398	CbGeAlD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—TYMP—esophageal cancer	0.00779	0.0256	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—RUNX3—esophageal cancer	0.00733	0.0241	CbGpPWpGaD
Ribavirin—NT5C2—lung—esophageal cancer	0.0073	0.0353	CbGeAlD
Ribavirin—ADK—bronchus—esophageal cancer	0.00724	0.035	CbGeAlD
Ribavirin—ADK—smooth muscle tissue—esophageal cancer	0.00709	0.0342	CbGeAlD
Ribavirin—NT5C2—Nucleotide metabolism—TYMP—esophageal cancer	0.00692	0.0228	CbGpPWpGaD
Ribavirin—ENPP1—lymph node—esophageal cancer	0.00684	0.033	CbGeAlD
Ribavirin—ADK—trachea—esophageal cancer	0.0065	0.0314	CbGeAlD
Ribavirin—SLC29A1—bronchus—esophageal cancer	0.00617	0.0298	CbGeAlD
Ribavirin—IMPDH1—lung—esophageal cancer	0.00593	0.0286	CbGeAlD
Ribavirin—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—esophageal cancer	0.00574	0.0189	CbGpPWpGaD
Ribavirin—IMPDH1—Nucleotide metabolism—TYMP—esophageal cancer	0.00564	0.0186	CbGpPWpGaD
Ribavirin—SLC29A1—trachea—esophageal cancer	0.00554	0.0267	CbGeAlD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—CYP2A6—esophageal cancer	0.0054	0.0177	CbGpPWpGaD
Ribavirin—ADK—Nucleotide metabolism—TYMP—esophageal cancer	0.00525	0.0172	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—MAP3K3—esophageal cancer	0.00514	0.0169	CbGpPWpGaD
Ribavirin—NT5C2—lymph node—esophageal cancer	0.00499	0.0241	CbGeAlD
Ribavirin—SLC29A1—digestive system—esophageal cancer	0.00476	0.023	CbGeAlD
Ribavirin—ADK—lung—esophageal cancer	0.00467	0.0226	CbGeAlD
Ribavirin—ENPP1—Insulin Signaling—XBP1—esophageal cancer	0.00465	0.0153	CbGpPWpGaD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—SMUG1—esophageal cancer	0.00439	0.0144	CbGpPWpGaD
Ribavirin—IMPDH1—lymph node—esophageal cancer	0.00405	0.0196	CbGeAlD
Ribavirin—SLC29A1—lung—esophageal cancer	0.00398	0.0192	CbGeAlD
Ribavirin—ADK—lymph node—esophageal cancer	0.0032	0.0154	CbGeAlD
Ribavirin—SLC29A1—lymph node—esophageal cancer	0.00272	0.0131	CbGeAlD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00251	0.00823	CbGpPWpGaD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00229	0.00753	CbGpPWpGaD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00187	0.00614	CbGpPWpGaD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00171	0.00561	CbGpPWpGaD
Ribavirin—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—esophageal cancer	0.0016	0.00525	CbGpPWpGaD
Ribavirin—Adenosine monophosphate—PDE4D—esophageal cancer	0.00152	1	CrCbGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00143	0.00469	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.00134	0.00441	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00127	0.00418	CbGpPWpGaD
Ribavirin—ENPP1—Disease—SLC52A3—esophageal cancer	0.00124	0.00407	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00121	0.00399	CbGpPWpGaD
Ribavirin—ENPP1—Disease—KMT2D—esophageal cancer	0.00118	0.00389	CbGpPWpGaD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—TP53—esophageal cancer	0.00117	0.00384	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00116	0.00383	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00116	0.00383	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00106	0.0035	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—BLVRB—esophageal cancer	0.00104	0.00341	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—BLVRB—esophageal cancer	0.00104	0.00341	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—SLC52A3—esophageal cancer	0.00104	0.00341	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—SLC52A3—esophageal cancer	0.00104	0.00341	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.001	0.00329	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000949	0.00312	CbGpPWpGaD
Ribavirin—ENPP1—Disease—FKBP1A—esophageal cancer	0.000917	0.00301	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000905	0.00298	CbGpPWpGaD
Ribavirin—ENPP1—Disease—WIF1—esophageal cancer	0.000896	0.00295	CbGpPWpGaD
Ribavirin—ENPP1—Disease—DOCK2—esophageal cancer	0.000896	0.00295	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CA1—esophageal cancer	0.000883	0.0029	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CA1—esophageal cancer	0.000883	0.0029	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—SLC10A2—esophageal cancer	0.000883	0.0029	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—SLC10A2—esophageal cancer	0.000883	0.0029	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000882	0.0029	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000868	0.00285	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000868	0.00285	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—SLC52A3—esophageal cancer	0.000846	0.00278	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—BLVRB—esophageal cancer	0.000846	0.00278	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CSNK1A1—esophageal cancer	0.000827	0.00272	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CA2—esophageal cancer	0.000807	0.00265	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CA2—esophageal cancer	0.000807	0.00265	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000801	0.00263	CbGpPWpGaD
Ribavirin—ADK—Metabolism—BLVRB—esophageal cancer	0.000787	0.00259	CbGpPWpGaD
Ribavirin—ADK—Metabolism—SLC52A3—esophageal cancer	0.000787	0.00259	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PLCE1—esophageal cancer	0.000751	0.00247	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—ADH7—esophageal cancer	0.000751	0.00247	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PLCE1—esophageal cancer	0.000751	0.00247	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ADH7—esophageal cancer	0.000751	0.00247	CbGpPWpGaD
Ribavirin—Abdominal distension—Capecitabine—esophageal cancer	0.000734	0.00151	CcSEcCtD
Ribavirin—Asthma—Capecitabine—esophageal cancer	0.000729	0.0015	CcSEcCtD
Ribavirin—Influenza—Capecitabine—esophageal cancer	0.000729	0.0015	CcSEcCtD
Ribavirin—Diabetes mellitus—Methotrexate—esophageal cancer	0.000722	0.00148	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—SLC10A2—esophageal cancer	0.00072	0.00237	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—CA1—esophageal cancer	0.00072	0.00237	CbGpPWpGaD
Ribavirin—Bronchospasm—Capecitabine—esophageal cancer	0.000717	0.00147	CcSEcCtD
Ribavirin—Polyuria—Methotrexate—esophageal cancer	0.000715	0.00147	CcSEcCtD
Ribavirin—Immune system disorder—Cisplatin—esophageal cancer	0.000715	0.00147	CcSEcCtD
Ribavirin—Mediastinal disorder—Cisplatin—esophageal cancer	0.000714	0.00147	CcSEcCtD
Ribavirin—Angina pectoris—Capecitabine—esophageal cancer	0.00071	0.00146	CcSEcCtD
Ribavirin—Sweating increased—Capecitabine—esophageal cancer	0.00071	0.00146	CcSEcCtD
Ribavirin—Arrhythmia—Cisplatin—esophageal cancer	0.000707	0.00145	CcSEcCtD
Ribavirin—Bronchitis—Capecitabine—esophageal cancer	0.000701	0.00144	CcSEcCtD
Ribavirin—Alopecia—Cisplatin—esophageal cancer	0.0007	0.00144	CcSEcCtD
Ribavirin—Abdominal discomfort—Capecitabine—esophageal cancer	0.000699	0.00144	CcSEcCtD
Ribavirin—Hepatic failure—Methotrexate—esophageal cancer	0.000699	0.00143	CcSEcCtD
Ribavirin—ENPP1—Disease—ELMO1—esophageal cancer	0.000695	0.00228	CbGpPWpGaD
Ribavirin—Erythema—Cisplatin—esophageal cancer	0.000689	0.00142	CcSEcCtD
Ribavirin—Malnutrition—Cisplatin—esophageal cancer	0.000689	0.00142	CcSEcCtD
Ribavirin—Neutropenia—Capecitabine—esophageal cancer	0.000682	0.0014	CcSEcCtD
Ribavirin—Flatulence—Cisplatin—esophageal cancer	0.000679	0.00139	CcSEcCtD
Ribavirin—ENPP1—Disease—GSTO1—esophageal cancer	0.000679	0.00223	CbGpPWpGaD
Ribavirin—ENPP1—Disease—TPI1—esophageal cancer	0.000679	0.00223	CbGpPWpGaD
Ribavirin—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000678	0.00139	CcSEcCtD
Ribavirin—ADK—Metabolism—SLC10A2—esophageal cancer	0.000669	0.0022	CbGpPWpGaD
Ribavirin—ADK—Metabolism—CA1—esophageal cancer	0.000669	0.0022	CbGpPWpGaD
Ribavirin—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000666	0.00137	CcSEcCtD
Ribavirin—Weight increased—Capecitabine—esophageal cancer	0.000664	0.00136	CcSEcCtD
Ribavirin—Visual disturbance—Methotrexate—esophageal cancer	0.000663	0.00136	CcSEcCtD
Ribavirin—Muscle spasms—Cisplatin—esophageal cancer	0.000663	0.00136	CcSEcCtD
Ribavirin—Weight decreased—Capecitabine—esophageal cancer	0.00066	0.00135	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—CA2—esophageal cancer	0.000658	0.00216	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—ADH1B—esophageal cancer	0.000658	0.00216	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ADH1B—esophageal cancer	0.000658	0.00216	CbGpPWpGaD
Ribavirin—Hyperglycaemia—Capecitabine—esophageal cancer	0.000658	0.00135	CcSEcCtD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000658	0.00216	CbGpPWpGaD
Ribavirin—Pneumonia—Capecitabine—esophageal cancer	0.000654	0.00134	CcSEcCtD
Ribavirin—ENPP1—Disease—ALDOB—esophageal cancer	0.000651	0.00214	CbGpPWpGaD
Ribavirin—Infestation—Capecitabine—esophageal cancer	0.00065	0.00133	CcSEcCtD
Ribavirin—Infestation NOS—Capecitabine—esophageal cancer	0.00065	0.00133	CcSEcCtD
Ribavirin—Vision blurred—Cisplatin—esophageal cancer	0.00065	0.00133	CcSEcCtD
Ribavirin—Depression—Capecitabine—esophageal cancer	0.000648	0.00133	CcSEcCtD
Ribavirin—Tremor—Cisplatin—esophageal cancer	0.000646	0.00133	CcSEcCtD
Ribavirin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000645	0.00132	CcSEcCtD
Ribavirin—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000641	0.00132	CcSEcCtD
Ribavirin—Lethargy—Methotrexate—esophageal cancer	0.000641	0.00132	CcSEcCtD
Ribavirin—Ill-defined disorder—Cisplatin—esophageal cancer	0.00064	0.00131	CcSEcCtD
Ribavirin—Renal failure—Capecitabine—esophageal cancer	0.000639	0.00131	CcSEcCtD
Ribavirin—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000637	0.00131	CcSEcCtD
Ribavirin—Myocardial infarction—Capecitabine—esophageal cancer	0.000637	0.00131	CcSEcCtD
Ribavirin—Anaemia—Cisplatin—esophageal cancer	0.000637	0.00131	CcSEcCtD
Ribavirin—Jaundice—Capecitabine—esophageal cancer	0.000634	0.0013	CcSEcCtD
Ribavirin—Stomatitis—Capecitabine—esophageal cancer	0.000634	0.0013	CcSEcCtD
Ribavirin—Urinary tract infection—Capecitabine—esophageal cancer	0.000632	0.0013	CcSEcCtD
Ribavirin—Conjunctivitis—Capecitabine—esophageal cancer	0.000632	0.0013	CcSEcCtD
Ribavirin—NT5C2—Metabolism—TYMP—esophageal cancer	0.000629	0.00207	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—TYMP—esophageal cancer	0.000629	0.00207	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HIST1H2BM—esophageal cancer	0.000627	0.00206	CbGpPWpGaD
Ribavirin—ENPP1—Disease—GAPDH—esophageal cancer	0.000627	0.00206	CbGpPWpGaD
Ribavirin—Malaise—Cisplatin—esophageal cancer	0.000622	0.00128	CcSEcCtD
Ribavirin—Leukopenia—Cisplatin—esophageal cancer	0.000617	0.00127	CcSEcCtD
Ribavirin—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000615	0.00126	CcSEcCtD
Ribavirin—Epistaxis—Capecitabine—esophageal cancer	0.000613	0.00126	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—ADH7—esophageal cancer	0.000612	0.00201	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PLCE1—esophageal cancer	0.000612	0.00201	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CYP26A1—esophageal cancer	0.000612	0.00201	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CYP26A1—esophageal cancer	0.000612	0.00201	CbGpPWpGaD
Ribavirin—ADK—Metabolism—CA2—esophageal cancer	0.000612	0.00201	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—PIK3CA—esophageal cancer	0.000604	0.00198	CbGpPWpGaD
Ribavirin—Irritability—Methotrexate—esophageal cancer	0.0006	0.00123	CcSEcCtD
Ribavirin—Convulsion—Cisplatin—esophageal cancer	0.000597	0.00123	CcSEcCtD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000597	0.00196	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ALOX15—esophageal cancer	0.000596	0.00196	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—ALOX15—esophageal cancer	0.000596	0.00196	CbGpPWpGaD
Ribavirin—Mood swings—Methotrexate—esophageal cancer	0.000595	0.00122	CcSEcCtD
Ribavirin—Bradycardia—Capecitabine—esophageal cancer	0.000594	0.00122	CcSEcCtD
Ribavirin—Ataxia—Methotrexate—esophageal cancer	0.000591	0.00121	CcSEcCtD
Ribavirin—Myalgia—Cisplatin—esophageal cancer	0.000587	0.0012	CcSEcCtD
Ribavirin—Haemoglobin—Capecitabine—esophageal cancer	0.000587	0.0012	CcSEcCtD
Ribavirin—Rhinitis—Capecitabine—esophageal cancer	0.000585	0.0012	CcSEcCtD
Ribavirin—Anxiety—Cisplatin—esophageal cancer	0.000585	0.0012	CcSEcCtD
Ribavirin—Hepatitis—Capecitabine—esophageal cancer	0.000584	0.0012	CcSEcCtD
Ribavirin—Haemorrhage—Capecitabine—esophageal cancer	0.000584	0.0012	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000583	0.0012	CcSEcCtD
Ribavirin—Hypoaesthesia—Capecitabine—esophageal cancer	0.000581	0.00119	CcSEcCtD
Ribavirin—Discomfort—Cisplatin—esophageal cancer	0.00058	0.00119	CcSEcCtD
Ribavirin—Pharyngitis—Capecitabine—esophageal cancer	0.000579	0.00119	CcSEcCtD
Ribavirin—Urinary tract disorder—Capecitabine—esophageal cancer	0.000577	0.00118	CcSEcCtD
Ribavirin—Oedema peripheral—Capecitabine—esophageal cancer	0.000575	0.00118	CcSEcCtD
Ribavirin—Connective tissue disorder—Capecitabine—esophageal cancer	0.000574	0.00118	CcSEcCtD
Ribavirin—Urethral disorder—Capecitabine—esophageal cancer	0.000572	0.00117	CcSEcCtD
Ribavirin—ENPP1—Metabolism—TPI1—esophageal cancer	0.000569	0.00187	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—TPI1—esophageal cancer	0.000569	0.00187	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—GSTO1—esophageal cancer	0.000569	0.00187	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GSTO1—esophageal cancer	0.000569	0.00187	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ADH7—esophageal cancer	0.000569	0.00187	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PLCE1—esophageal cancer	0.000569	0.00187	CbGpPWpGaD
Ribavirin—Breast disorder—Methotrexate—esophageal cancer	0.000568	0.00117	CcSEcCtD
Ribavirin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000566	0.00116	CcSEcCtD
Ribavirin—Oedema—Cisplatin—esophageal cancer	0.000563	0.00115	CcSEcCtD
Ribavirin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000563	0.00115	CcSEcCtD
Ribavirin—Visual impairment—Capecitabine—esophageal cancer	0.000563	0.00115	CcSEcCtD
Ribavirin—ENPP1—Disease—XIAP—esophageal cancer	0.000554	0.00182	CbGpPWpGaD
Ribavirin—Erythema multiforme—Capecitabine—esophageal cancer	0.000552	0.00113	CcSEcCtD
Ribavirin—Nervous system disorder—Cisplatin—esophageal cancer	0.000552	0.00113	CcSEcCtD
Ribavirin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000551	0.00113	CcSEcCtD
Ribavirin—Tachycardia—Cisplatin—esophageal cancer	0.000549	0.00113	CcSEcCtD
Ribavirin—Skin disorder—Cisplatin—esophageal cancer	0.000547	0.00112	CcSEcCtD
Ribavirin—Eye disorder—Capecitabine—esophageal cancer	0.000546	0.00112	CcSEcCtD
Ribavirin—ENPP1—Metabolism—ALDOB—esophageal cancer	0.000545	0.00179	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ALDOB—esophageal cancer	0.000545	0.00179	CbGpPWpGaD
Ribavirin—Tinnitus—Capecitabine—esophageal cancer	0.000544	0.00112	CcSEcCtD
Ribavirin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000544	0.00112	CcSEcCtD
Ribavirin—Asthma—Methotrexate—esophageal cancer	0.000543	0.00111	CcSEcCtD
Ribavirin—Flushing—Capecitabine—esophageal cancer	0.000542	0.00111	CcSEcCtD
Ribavirin—Cardiac disorder—Capecitabine—esophageal cancer	0.000542	0.00111	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—ADH1B—esophageal cancer	0.000536	0.00176	CbGpPWpGaD
Ribavirin—Anorexia—Cisplatin—esophageal cancer	0.000536	0.0011	CcSEcCtD
Ribavirin—Pancreatitis—Methotrexate—esophageal cancer	0.000532	0.00109	CcSEcCtD
Ribavirin—Angiopathy—Capecitabine—esophageal cancer	0.00053	0.00109	CcSEcCtD
Ribavirin—Immune system disorder—Capecitabine—esophageal cancer	0.000527	0.00108	CcSEcCtD
Ribavirin—Mediastinal disorder—Capecitabine—esophageal cancer	0.000526	0.00108	CcSEcCtD
Ribavirin—Hypotension—Cisplatin—esophageal cancer	0.000526	0.00108	CcSEcCtD
Ribavirin—NT5C2—Metabolism—GAPDH—esophageal cancer	0.000525	0.00173	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GAPDH—esophageal cancer	0.000525	0.00173	CbGpPWpGaD
Ribavirin—Chills—Capecitabine—esophageal cancer	0.000524	0.00108	CcSEcCtD
Ribavirin—Arrhythmia—Capecitabine—esophageal cancer	0.000522	0.00107	CcSEcCtD
Ribavirin—Abdominal discomfort—Methotrexate—esophageal cancer	0.000521	0.00107	CcSEcCtD
Ribavirin—NT5C2—Metabolism—CRABP1—esophageal cancer	0.00052	0.00171	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CRABP1—esophageal cancer	0.00052	0.00171	CbGpPWpGaD
Ribavirin—Alopecia—Capecitabine—esophageal cancer	0.000516	0.00106	CcSEcCtD
Ribavirin—ENPP1—Disease—B2M—esophageal cancer	0.000515	0.00169	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—TYMP—esophageal cancer	0.000513	0.00169	CbGpPWpGaD
Ribavirin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000513	0.00105	CcSEcCtD
Ribavirin—Mental disorder—Capecitabine—esophageal cancer	0.000511	0.00105	CcSEcCtD
Ribavirin—Erythema—Capecitabine—esophageal cancer	0.000508	0.00104	CcSEcCtD
Ribavirin—Malnutrition—Capecitabine—esophageal cancer	0.000508	0.00104	CcSEcCtD
Ribavirin—Neutropenia—Methotrexate—esophageal cancer	0.000508	0.00104	CcSEcCtD
Ribavirin—Paraesthesia—Cisplatin—esophageal cancer	0.000505	0.00104	CcSEcCtD
Ribavirin—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000505	0.00104	CcSEcCtD
Ribavirin—Dyspnoea—Cisplatin—esophageal cancer	0.000502	0.00103	CcSEcCtD
Ribavirin—Flatulence—Capecitabine—esophageal cancer	0.000501	0.00103	CcSEcCtD
Ribavirin—Erectile dysfunction—Methotrexate—esophageal cancer	0.0005	0.00103	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—CYP26A1—esophageal cancer	0.000499	0.00164	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ADH1B—esophageal cancer	0.000499	0.00164	CbGpPWpGaD
Ribavirin—Dysgeusia—Capecitabine—esophageal cancer	0.000498	0.00102	CcSEcCtD
Ribavirin—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000496	0.00102	CcSEcCtD
Ribavirin—ENPP1—Metabolism—GNG7—esophageal cancer	0.000495	0.00163	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—GNG7—esophageal cancer	0.000495	0.00163	CbGpPWpGaD
Ribavirin—ENPP1—Disease—ENO1—esophageal cancer	0.000493	0.00162	CbGpPWpGaD
Ribavirin—Back pain—Capecitabine—esophageal cancer	0.000492	0.00101	CcSEcCtD
Ribavirin—Decreased appetite—Cisplatin—esophageal cancer	0.000489	0.001	CcSEcCtD
Ribavirin—Muscle spasms—Capecitabine—esophageal cancer	0.000489	0.001	CcSEcCtD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000488	0.0016	CbGpPWpGaD
Ribavirin—Pneumonia—Methotrexate—esophageal cancer	0.000487	0.000999	CcSEcCtD
Ribavirin—ENPP1—Disease—PSME1—esophageal cancer	0.000486	0.0016	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PSME2—esophageal cancer	0.000486	0.0016	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—ALOX15—esophageal cancer	0.000486	0.0016	CbGpPWpGaD
Ribavirin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000486	0.000997	CcSEcCtD
Ribavirin—Infestation NOS—Methotrexate—esophageal cancer	0.000484	0.000994	CcSEcCtD
Ribavirin—Infestation—Methotrexate—esophageal cancer	0.000484	0.000994	CcSEcCtD
Ribavirin—Depression—Methotrexate—esophageal cancer	0.000483	0.000991	CcSEcCtD
Ribavirin—Pain—Cisplatin—esophageal cancer	0.000481	0.000988	CcSEcCtD
Ribavirin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00048	0.000985	CcSEcCtD
Ribavirin—Vision blurred—Capecitabine—esophageal cancer	0.000479	0.000983	CcSEcCtD
Ribavirin—ADK—Metabolism—TYMP—esophageal cancer	0.000477	0.00157	CbGpPWpGaD
Ribavirin—Tremor—Capecitabine—esophageal cancer	0.000476	0.000977	CcSEcCtD
Ribavirin—Renal failure—Methotrexate—esophageal cancer	0.000476	0.000977	CcSEcCtD
Ribavirin—Stomatitis—Methotrexate—esophageal cancer	0.000472	0.000969	CcSEcCtD
Ribavirin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000472	0.000968	CcSEcCtD
Ribavirin—Conjunctivitis—Methotrexate—esophageal cancer	0.000471	0.000966	CcSEcCtD
Ribavirin—Anaemia—Capecitabine—esophageal cancer	0.00047	0.000964	CcSEcCtD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000468	0.00154	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CALR—esophageal cancer	0.000467	0.00153	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—TPI1—esophageal cancer	0.000464	0.00152	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—GSTO1—esophageal cancer	0.000464	0.00152	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ALDH2—esophageal cancer	0.000464	0.00152	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—ALDH2—esophageal cancer	0.000464	0.00152	CbGpPWpGaD
Ribavirin—ADK—Metabolism—CYP26A1—esophageal cancer	0.000464	0.00152	CbGpPWpGaD
Ribavirin—Feeling abnormal—Cisplatin—esophageal cancer	0.000464	0.000952	CcSEcCtD
Ribavirin—Malaise—Capecitabine—esophageal cancer	0.000458	0.000941	CcSEcCtD
Ribavirin—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000458	0.00094	CcSEcCtD
Ribavirin—Epistaxis—Methotrexate—esophageal cancer	0.000457	0.000937	CcSEcCtD
Ribavirin—Vertigo—Capecitabine—esophageal cancer	0.000457	0.000937	CcSEcCtD
Ribavirin—Syncope—Capecitabine—esophageal cancer	0.000456	0.000935	CcSEcCtD
Ribavirin—Leukopenia—Capecitabine—esophageal cancer	0.000455	0.000934	CcSEcCtD
Ribavirin—ADK—Metabolism—ALOX15—esophageal cancer	0.000452	0.00149	CbGpPWpGaD
Ribavirin—ENPP1—Disease—FBXW7—esophageal cancer	0.000451	0.00148	CbGpPWpGaD
Ribavirin—Palpitations—Capecitabine—esophageal cancer	0.000449	0.000922	CcSEcCtD
Ribavirin—Loss of consciousness—Capecitabine—esophageal cancer	0.000447	0.000917	CcSEcCtD
Ribavirin—Body temperature increased—Cisplatin—esophageal cancer	0.000445	0.000913	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—ALDOB—esophageal cancer	0.000445	0.00146	CbGpPWpGaD
Ribavirin—Cough—Capecitabine—esophageal cancer	0.000443	0.00091	CcSEcCtD
Ribavirin—NT5C2—Metabolism—GSTT1—esophageal cancer	0.000441	0.00145	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GSTT1—esophageal cancer	0.000441	0.00145	CbGpPWpGaD
Ribavirin—Hypertension—Capecitabine—esophageal cancer	0.000439	0.000901	CcSEcCtD
Ribavirin—Haemoglobin—Methotrexate—esophageal cancer	0.000437	0.000897	CcSEcCtD
Ribavirin—NT5C2—Metabolism—CYP2A6—esophageal cancer	0.000436	0.00143	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CYP2A6—esophageal cancer	0.000436	0.00143	CbGpPWpGaD
Ribavirin—Hepatitis—Methotrexate—esophageal cancer	0.000435	0.000892	CcSEcCtD
Ribavirin—Haemorrhage—Methotrexate—esophageal cancer	0.000435	0.000892	CcSEcCtD
Ribavirin—Arthralgia—Capecitabine—esophageal cancer	0.000433	0.000888	CcSEcCtD
Ribavirin—Chest pain—Capecitabine—esophageal cancer	0.000433	0.000888	CcSEcCtD
Ribavirin—Myalgia—Capecitabine—esophageal cancer	0.000433	0.000888	CcSEcCtD
Ribavirin—Pharyngitis—Methotrexate—esophageal cancer	0.000431	0.000885	CcSEcCtD
Ribavirin—Anxiety—Capecitabine—esophageal cancer	0.000431	0.000885	CcSEcCtD
Ribavirin—ADK—Metabolism—TPI1—esophageal cancer	0.000431	0.00142	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GSTO1—esophageal cancer	0.000431	0.00142	CbGpPWpGaD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00043	0.000882	CcSEcCtD
Ribavirin—Urinary tract disorder—Methotrexate—esophageal cancer	0.000429	0.000881	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—GAPDH—esophageal cancer	0.000428	0.00141	CbGpPWpGaD
Ribavirin—Discomfort—Capecitabine—esophageal cancer	0.000427	0.000877	CcSEcCtD
Ribavirin—Urethral disorder—Methotrexate—esophageal cancer	0.000426	0.000874	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—CRABP1—esophageal cancer	0.000424	0.00139	CbGpPWpGaD
Ribavirin—Dry mouth—Capecitabine—esophageal cancer	0.000423	0.000869	CcSEcCtD
Ribavirin—Visual impairment—Methotrexate—esophageal cancer	0.000419	0.00086	CcSEcCtD
Ribavirin—Confusional state—Capecitabine—esophageal cancer	0.000418	0.000858	CcSEcCtD
Ribavirin—Oedema—Capecitabine—esophageal cancer	0.000415	0.000851	CcSEcCtD
Ribavirin—Hypersensitivity—Cisplatin—esophageal cancer	0.000415	0.000851	CcSEcCtD
Ribavirin—NT5C2—Metabolism—PTGS1—esophageal cancer	0.000413	0.00136	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PTGS1—esophageal cancer	0.000413	0.00136	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—ENO1—esophageal cancer	0.000413	0.00136	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ENO1—esophageal cancer	0.000413	0.00136	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ALDOB—esophageal cancer	0.000413	0.00136	CbGpPWpGaD
Ribavirin—Erythema multiforme—Methotrexate—esophageal cancer	0.000411	0.000843	CcSEcCtD
Ribavirin—Shock—Capecitabine—esophageal cancer	0.000408	0.000838	CcSEcCtD
Ribavirin—ENPP1—Metabolism—PSME1—esophageal cancer	0.000407	0.00134	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PSME1—esophageal cancer	0.000407	0.00134	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PSME2—esophageal cancer	0.000407	0.00134	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PSME2—esophageal cancer	0.000407	0.00134	CbGpPWpGaD
Ribavirin—Nervous system disorder—Capecitabine—esophageal cancer	0.000407	0.000835	CcSEcCtD
Ribavirin—Eye disorder—Methotrexate—esophageal cancer	0.000406	0.000834	CcSEcCtD
Ribavirin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000406	0.000834	CcSEcCtD
Ribavirin—Tinnitus—Methotrexate—esophageal cancer	0.000405	0.000832	CcSEcCtD
Ribavirin—Tachycardia—Capecitabine—esophageal cancer	0.000405	0.000831	CcSEcCtD
Ribavirin—Asthenia—Cisplatin—esophageal cancer	0.000404	0.000829	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—GNG7—esophageal cancer	0.000403	0.00133	CbGpPWpGaD
Ribavirin—Cardiac disorder—Methotrexate—esophageal cancer	0.000403	0.000828	CcSEcCtD
Ribavirin—Skin disorder—Capecitabine—esophageal cancer	0.000403	0.000827	CcSEcCtD
Ribavirin—Hyperhidrosis—Capecitabine—esophageal cancer	0.000401	0.000823	CcSEcCtD
Ribavirin—ADK—Metabolism—GAPDH—esophageal cancer	0.000398	0.00131	CbGpPWpGaD
Ribavirin—Anorexia—Capecitabine—esophageal cancer	0.000395	0.000812	CcSEcCtD
Ribavirin—Angiopathy—Methotrexate—esophageal cancer	0.000394	0.000809	CcSEcCtD
Ribavirin—ADK—Metabolism—CRABP1—esophageal cancer	0.000394	0.0013	CbGpPWpGaD
Ribavirin—Immune system disorder—Methotrexate—esophageal cancer	0.000393	0.000806	CcSEcCtD
Ribavirin—Mediastinal disorder—Methotrexate—esophageal cancer	0.000392	0.000804	CcSEcCtD
Ribavirin—Chills—Methotrexate—esophageal cancer	0.00039	0.0008	CcSEcCtD
Ribavirin—Hypotension—Capecitabine—esophageal cancer	0.000388	0.000796	CcSEcCtD
Ribavirin—Diarrhoea—Cisplatin—esophageal cancer	0.000385	0.00079	CcSEcCtD
Ribavirin—Alopecia—Methotrexate—esophageal cancer	0.000384	0.000788	CcSEcCtD
Ribavirin—Mental disorder—Methotrexate—esophageal cancer	0.000381	0.000782	CcSEcCtD
Ribavirin—Malnutrition—Methotrexate—esophageal cancer	0.000378	0.000777	CcSEcCtD
Ribavirin—Erythema—Methotrexate—esophageal cancer	0.000378	0.000777	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—ALDH2—esophageal cancer	0.000378	0.00124	CbGpPWpGaD
Ribavirin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000378	0.000776	CcSEcCtD
Ribavirin—Insomnia—Capecitabine—esophageal cancer	0.000375	0.00077	CcSEcCtD
Ribavirin—ADK—Metabolism—GNG7—esophageal cancer	0.000375	0.00123	CbGpPWpGaD
Ribavirin—Paraesthesia—Capecitabine—esophageal cancer	0.000372	0.000764	CcSEcCtD
Ribavirin—Dysgeusia—Methotrexate—esophageal cancer	0.00037	0.00076	CcSEcCtD
Ribavirin—Dyspnoea—Capecitabine—esophageal cancer	0.00037	0.000759	CcSEcCtD
Ribavirin—Back pain—Methotrexate—esophageal cancer	0.000366	0.000751	CcSEcCtD
Ribavirin—Dyspepsia—Capecitabine—esophageal cancer	0.000365	0.000749	CcSEcCtD
Ribavirin—ENPP1—Disease—TGFBR2—esophageal cancer	0.000365	0.0012	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000364	0.0012	CbGpPWpGaD
Ribavirin—Decreased appetite—Capecitabine—esophageal cancer	0.000361	0.00074	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—GSTT1—esophageal cancer	0.00036	0.00118	CbGpPWpGaD
Ribavirin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000358	0.000735	CcSEcCtD
Ribavirin—Vomiting—Cisplatin—esophageal cancer	0.000358	0.000734	CcSEcCtD
Ribavirin—Fatigue—Capecitabine—esophageal cancer	0.000358	0.000734	CcSEcCtD
Ribavirin—Vision blurred—Methotrexate—esophageal cancer	0.000357	0.000732	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—CYP2A6—esophageal cancer	0.000355	0.00117	CbGpPWpGaD
Ribavirin—Rash—Cisplatin—esophageal cancer	0.000355	0.000728	CcSEcCtD
Ribavirin—Pain—Capecitabine—esophageal cancer	0.000355	0.000728	CcSEcCtD
Ribavirin—Constipation—Capecitabine—esophageal cancer	0.000355	0.000728	CcSEcCtD
Ribavirin—Dermatitis—Cisplatin—esophageal cancer	0.000354	0.000728	CcSEcCtD
Ribavirin—ENPP1—Metabolism—CYP1B1—esophageal cancer	0.000351	0.00116	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CYP1B1—esophageal cancer	0.000351	0.00116	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ALDH2—esophageal cancer	0.000351	0.00116	CbGpPWpGaD
Ribavirin—Ill-defined disorder—Methotrexate—esophageal cancer	0.000351	0.000721	CcSEcCtD
Ribavirin—Anaemia—Methotrexate—esophageal cancer	0.00035	0.000718	CcSEcCtD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000349	0.00115	CbGpPWpGaD
Ribavirin—ENPP1—Disease—SMAD4—esophageal cancer	0.000346	0.00114	CbGpPWpGaD
Ribavirin—Feeling abnormal—Capecitabine—esophageal cancer	0.000342	0.000702	CcSEcCtD
Ribavirin—Malaise—Methotrexate—esophageal cancer	0.000341	0.0007	CcSEcCtD
Ribavirin—Vertigo—Methotrexate—esophageal cancer	0.00034	0.000698	CcSEcCtD
Ribavirin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000339	0.000696	CcSEcCtD
Ribavirin—Leukopenia—Methotrexate—esophageal cancer	0.000339	0.000695	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—ENO1—esophageal cancer	0.000337	0.00111	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PTGS1—esophageal cancer	0.000337	0.00111	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GSTT1—esophageal cancer	0.000334	0.0011	CbGpPWpGaD
Ribavirin—Nausea—Cisplatin—esophageal cancer	0.000334	0.000686	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—PSME1—esophageal cancer	0.000332	0.00109	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PSME2—esophageal cancer	0.000332	0.00109	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CYP19A1—esophageal cancer	0.00033	0.00109	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CYP19A1—esophageal cancer	0.00033	0.00109	CbGpPWpGaD
Ribavirin—ADK—Metabolism—CYP2A6—esophageal cancer	0.00033	0.00109	CbGpPWpGaD
Ribavirin—Cough—Methotrexate—esophageal cancer	0.00033	0.000678	CcSEcCtD
Ribavirin—Urticaria—Capecitabine—esophageal cancer	0.000329	0.000676	CcSEcCtD
Ribavirin—Abdominal pain—Capecitabine—esophageal cancer	0.000328	0.000673	CcSEcCtD
Ribavirin—Body temperature increased—Capecitabine—esophageal cancer	0.000328	0.000673	CcSEcCtD
Ribavirin—Convulsion—Methotrexate—esophageal cancer	0.000328	0.000673	CcSEcCtD
Ribavirin—Arthralgia—Methotrexate—esophageal cancer	0.000322	0.000661	CcSEcCtD
Ribavirin—Chest pain—Methotrexate—esophageal cancer	0.000322	0.000661	CcSEcCtD
Ribavirin—Myalgia—Methotrexate—esophageal cancer	0.000322	0.000661	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00032	0.000657	CcSEcCtD
Ribavirin—Discomfort—Methotrexate—esophageal cancer	0.000318	0.000653	CcSEcCtD
Ribavirin—ADK—Metabolism—ENO1—esophageal cancer	0.000313	0.00103	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PTGS1—esophageal cancer	0.000313	0.00103	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000313	0.00103	CbGpPWpGaD
Ribavirin—Confusional state—Methotrexate—esophageal cancer	0.000311	0.000639	CcSEcCtD
Ribavirin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000309	0.000634	CcSEcCtD
Ribavirin—ADK—Metabolism—PSME1—esophageal cancer	0.000309	0.00101	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PSME2—esophageal cancer	0.000309	0.00101	CbGpPWpGaD
Ribavirin—Hypersensitivity—Capecitabine—esophageal cancer	0.000306	0.000627	CcSEcCtD
Ribavirin—Nervous system disorder—Methotrexate—esophageal cancer	0.000303	0.000622	CcSEcCtD
Ribavirin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000302	0.000621	CcSEcCtD
Ribavirin—ENPP1—Metabolism—HMOX1—esophageal cancer	0.000301	0.000991	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—HMOX1—esophageal cancer	0.000301	0.000991	CbGpPWpGaD
Ribavirin—Skin disorder—Methotrexate—esophageal cancer	0.0003	0.000616	CcSEcCtD
Ribavirin—Hyperhidrosis—Methotrexate—esophageal cancer	0.000298	0.000613	CcSEcCtD
Ribavirin—Asthenia—Capecitabine—esophageal cancer	0.000298	0.000611	CcSEcCtD
Ribavirin—Anorexia—Methotrexate—esophageal cancer	0.000294	0.000604	CcSEcCtD
Ribavirin—Pruritus—Capecitabine—esophageal cancer	0.000293	0.000602	CcSEcCtD
Ribavirin—ENPP1—Metabolism—ABCB1—esophageal cancer	0.000289	0.000951	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ABCB1—esophageal cancer	0.000289	0.000951	CbGpPWpGaD
Ribavirin—Hypotension—Methotrexate—esophageal cancer	0.000289	0.000592	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—CYP1B1—esophageal cancer	0.000286	0.000942	CbGpPWpGaD
Ribavirin—Diarrhoea—Capecitabine—esophageal cancer	0.000284	0.000583	CcSEcCtD
Ribavirin—ENPP1—Disease—HIF1A—esophageal cancer	0.000283	0.000929	CbGpPWpGaD
Ribavirin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000281	0.000577	CcSEcCtD
Ribavirin—Insomnia—Methotrexate—esophageal cancer	0.000279	0.000573	CcSEcCtD
Ribavirin—Paraesthesia—Methotrexate—esophageal cancer	0.000277	0.000569	CcSEcCtD
Ribavirin—Dyspnoea—Methotrexate—esophageal cancer	0.000275	0.000565	CcSEcCtD
Ribavirin—Somnolence—Methotrexate—esophageal cancer	0.000274	0.000563	CcSEcCtD
Ribavirin—Dizziness—Capecitabine—esophageal cancer	0.000274	0.000563	CcSEcCtD
Ribavirin—Dyspepsia—Methotrexate—esophageal cancer	0.000272	0.000558	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—CYP19A1—esophageal cancer	0.000269	0.000885	CbGpPWpGaD
Ribavirin—Decreased appetite—Methotrexate—esophageal cancer	0.000268	0.000551	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000267	0.000547	CcSEcCtD
Ribavirin—ADK—Metabolism—CYP1B1—esophageal cancer	0.000266	0.000875	CbGpPWpGaD
Ribavirin—Fatigue—Methotrexate—esophageal cancer	0.000266	0.000546	CcSEcCtD
Ribavirin—Pain—Methotrexate—esophageal cancer	0.000264	0.000542	CcSEcCtD
Ribavirin—Vomiting—Capecitabine—esophageal cancer	0.000264	0.000541	CcSEcCtD
Ribavirin—Rash—Capecitabine—esophageal cancer	0.000262	0.000537	CcSEcCtD
Ribavirin—Dermatitis—Capecitabine—esophageal cancer	0.000261	0.000536	CcSEcCtD
Ribavirin—Headache—Capecitabine—esophageal cancer	0.00026	0.000533	CcSEcCtD
Ribavirin—ENPP1—Disease—NOS2—esophageal cancer	0.000257	0.000845	CbGpPWpGaD
Ribavirin—ENPP1—Disease—NOTCH1—esophageal cancer	0.000255	0.000837	CbGpPWpGaD
Ribavirin—Feeling abnormal—Methotrexate—esophageal cancer	0.000254	0.000522	CcSEcCtD
Ribavirin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000252	0.000518	CcSEcCtD
Ribavirin—ADK—Metabolism—CYP19A1—esophageal cancer	0.00025	0.000823	CbGpPWpGaD
Ribavirin—Nausea—Capecitabine—esophageal cancer	0.000246	0.000506	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—HMOX1—esophageal cancer	0.000246	0.000808	CbGpPWpGaD
Ribavirin—Urticaria—Methotrexate—esophageal cancer	0.000245	0.000503	CcSEcCtD
Ribavirin—Abdominal pain—Methotrexate—esophageal cancer	0.000244	0.000501	CcSEcCtD
Ribavirin—Body temperature increased—Methotrexate—esophageal cancer	0.000244	0.000501	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—ABCB1—esophageal cancer	0.000236	0.000775	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000233	0.000767	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CREBBP—esophageal cancer	0.000231	0.000759	CbGpPWpGaD
Ribavirin—ADK—Metabolism—HMOX1—esophageal cancer	0.000228	0.000751	CbGpPWpGaD
Ribavirin—Hypersensitivity—Methotrexate—esophageal cancer	0.000227	0.000467	CcSEcCtD
Ribavirin—Asthenia—Methotrexate—esophageal cancer	0.000222	0.000455	CcSEcCtD
Ribavirin—ADK—Metabolism—ABCB1—esophageal cancer	0.000219	0.000721	CbGpPWpGaD
Ribavirin—Pruritus—Methotrexate—esophageal cancer	0.000218	0.000448	CcSEcCtD
Ribavirin—Diarrhoea—Methotrexate—esophageal cancer	0.000211	0.000434	CcSEcCtD
Ribavirin—ENPP1—Disease—NOS3—esophageal cancer	0.000207	0.00068	CbGpPWpGaD
Ribavirin—Dizziness—Methotrexate—esophageal cancer	0.000204	0.000419	CcSEcCtD
Ribavirin—Vomiting—Methotrexate—esophageal cancer	0.000196	0.000403	CcSEcCtD
Ribavirin—Rash—Methotrexate—esophageal cancer	0.000195	0.0004	CcSEcCtD
Ribavirin—Dermatitis—Methotrexate—esophageal cancer	0.000194	0.000399	CcSEcCtD
Ribavirin—Headache—Methotrexate—esophageal cancer	0.000193	0.000397	CcSEcCtD
Ribavirin—ENPP1—Metabolism—CREBBP—esophageal cancer	0.000193	0.000636	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CREBBP—esophageal cancer	0.000193	0.000636	CbGpPWpGaD
Ribavirin—ENPP1—Disease—ERBB2—esophageal cancer	0.000193	0.000636	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PTGS2—esophageal cancer	0.000189	0.000622	CbGpPWpGaD
Ribavirin—Nausea—Methotrexate—esophageal cancer	0.000183	0.000376	CcSEcCtD
Ribavirin—NT5C2—Metabolism—NOS3—esophageal cancer	0.000173	0.000569	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—NOS3—esophageal cancer	0.000173	0.000569	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CDKN1A—esophageal cancer	0.000165	0.000543	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PTGS2—esophageal cancer	0.000158	0.000521	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PTGS2—esophageal cancer	0.000158	0.000521	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—CREBBP—esophageal cancer	0.000158	0.000518	CbGpPWpGaD
Ribavirin—ENPP1—Disease—EP300—esophageal cancer	0.000157	0.000517	CbGpPWpGaD
Ribavirin—ADK—Metabolism—CREBBP—esophageal cancer	0.000147	0.000482	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—NOS3—esophageal cancer	0.000141	0.000464	CbGpPWpGaD
Ribavirin—ENPP1—Disease—MYC—esophageal cancer	0.000137	0.00045	CbGpPWpGaD
Ribavirin—ENPP1—Disease—EGFR—esophageal cancer	0.000134	0.000441	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—EP300—esophageal cancer	0.000132	0.000433	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—EP300—esophageal cancer	0.000132	0.000433	CbGpPWpGaD
Ribavirin—ADK—Metabolism—NOS3—esophageal cancer	0.000131	0.000431	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PTGS2—esophageal cancer	0.000129	0.000424	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PTGS2—esophageal cancer	0.00012	0.000395	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PIK3CA—esophageal cancer	0.000116	0.000382	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—EP300—esophageal cancer	0.000107	0.000353	CbGpPWpGaD
Ribavirin—ADK—Metabolism—EP300—esophageal cancer	9.98e-05	0.000328	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PIK3CA—esophageal cancer	9.74e-05	0.00032	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PIK3CA—esophageal cancer	9.74e-05	0.00032	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PIK3CA—esophageal cancer	7.94e-05	0.000261	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PIK3CA—esophageal cancer	7.38e-05	0.000243	CbGpPWpGaD
